| # | Drug | Count |
|---|---|---|
| 0 | MIFEPRISTONE | 70 |
| 1 | LEVONORGESTREL | 62 |
| 2 | COPPER | 55 |
| 3 | ESTRADIOL | 39 |
| 4 | SPIRONOLACTONE | 36 |
| 5 | IBUPROFEN | 35 |
| 6 | IBUPFROFEN | 34 |
| 7 | IBUPROFEN 200 MG | 34 |
| 8 | IBUPROFEN 200MG | 34 |
| 9 | IBUPROFEN CAPSULE | 34 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MIFEPRISTONE | 70 | 0.0147 |
| 1 | TOREMIFENE CITRATE | 4 | 0.0093 |
| 2 | OSPEMIFENE | 19 | 0.0073 |
| 3 | CONJUGATED ESTROGENS/BAZEDOXIFENE | 6 | 0.0064 |
| 4 | ESTRADIOL AND NORETHINDRONE ACETATE | 2 | 0.0053 |
| 5 | AURANOFIN | 1 | 0.0049 |
| 6 | ARNICA MONTANA, HYPERICUM PERFORATUM, LEDUM PALUSTRE, MORBILLINUM, NATRUM MURIATICUM, SILICEA, SULPHUR IODATUM, THUJA OCCIDENTALIS, URTICA URENS | 1 | 0.0047 |
| 7 | SODIUM CARBONATE | 1 | 0.0043 |
| 8 | ESTRADIOL ACETATE | 3 | 0.0038 |
| 9 | DROSPIRENONE AND ESTETROL | 1 | 0.0034 |
| # | Drug class | Count |
|---|---|---|
| 0 | Progestin [EPC] | 73 |
| 1 | Progestin Antagonist [EPC] | 70 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 65 |
| 3 | Progestin-containing Intrauterine System [EPC] | 62 |
| 4 | Estrogen [EPC] | 59 |
| 5 | Copper-containing Intrauterine Device [EPC] | 55 |
| 6 | Aldosterone Antagonist [EPC] | 36 |
| 7 | Corticosteroid [EPC] | 34 |
| 8 | Progesterone [EPC] | 34 |
| 9 | GLP-1 Receptor Agonist [EPC] | 31 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Progestin Antagonist [EPC] | 70 | 0.0147 |
| 1 | Estrogen Agonist/Antagonist [EPC] | 19 | 0.0073 |
| 2 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 3 | Progesterone [EPC] | 34 | 0.0014 |
| 4 | Copper-containing Intrauterine Device [EPC] | 55 | 0.0011 |
| 5 | Provitamin D2 Compound [EPC] | 25 | 0.0008 |
| 6 | Ergot Derivative [EPC] | 3 | 0.0006 |
| 7 | Serotonin and Norepinephrine Reuptake Inhibitor [EPC] | 2 | 0.0005 |
| 8 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 9 | alpha-Hydroxy Acid [EPC] | 1 | 0.0005 |